Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B). - Yang JC; Wang M; Doucet L; Fan Y; Lv D; Sun M; Huang D; Greillier L; Planchard D; Hong Q; Mazieres J; Felip E; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025)